References
- Ohnuma, K., Toyoda, Y., Nishihira, H., Iguchi, A., Honda, K., Nagao, T., et al. (1997) "Aggressive natural killer (NK) cell lymphoma: Report of a pediatric case and review of the literature", Leukemia and Lymphoma, 25, 387— 392.
- Imamura, N., Kusunoki, Y., Kawa-Ha, K., Yimura, K., Hara, J., Oda, K., et al. (1990) "Aggressive natural killer cell leukemia/ lymphoma: report of four cases and review of the literature", British Journal of Haematology, 75, 49–59.
- Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., et al. (1996) "Fos ligand in human serum", Nature Medicine, 2, 317–322.
- Kato, K., Ohshima, K., Anzai, K., Anzai, K., Suzumiya, J. and Kikuchi, M. (2001) "Elevated serum-soluble Fas ligand in histiocytic necrotizing lymphadenitis", International Journal of Hematology, 73, 84–86.
- Hasegawa, D., Kojima, S., Tatsumi, E., Hayakawa, A., Kosaka, Y., Nakamura, H., et al. (1998) "Elevation of serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia", Blood, 91, 2793–2799.
- Kimura, H., Hoshino, Y., Kanegane, H., Tsuge, I., Okamura, T., Kawa, K., et al. (2001) "Clinical and virologic characteristics of chronic active Epstein-Barr virus infection", Blood, 98, 280–286.
- Aimi, S., Yasoshima, S., Sugai, M., Sato, B., Sakai, T. and Nakajima, Y. (1952) "Studies on the weight and size of internal organ of normal Japanese", Acta Path. Jap., 2, 173–200.
- Kato, K., Ohshima, K., Ishihara, S., Anzai, K., Suzumiya, J. and Kikuchi, M. (1998) "Elevated serum soluble Fas ligand in natural killer cell proliferative disorders", British Journal of Haematology, 103, 1164 — 1166.
- Yamamoto, T., Iwasaki, T. and Watanabe, N. (1993) "Expression of multidrug resistance P-glycoprotein on peripheral blood mono-nuclear cells of patients with granular lymphocyte-proliferative disorders", Blood, 81, 1342— 1346.
- Manabe, A., Takahashi, K., Shibata, R., Takeuchi, M., Morita, M. and Hosoya, R. (2000) "Long-term remission induced by corticos-teroids, cyclophosphamide, and methotrexate in a patient with natural killer cell leukemia", Medical and Pediatric Oncology, 34, 224–225.
- Imashuku, S., Obayashi, M., Hosoi, G., Sako, M., Chen, J., Mugishima, H., et al. (2000) "Splenectomy in haemophagocytic lymphohistiocytosis: report of histopathological changes with CD19 + B-cell depletion and therapeutic results", British Journal of Haematology, 108, 505–510.
- Kawa, K. (2003) "Diagnosis and treatment of Epstein-Barr virus — associated natural killer cell lymphoproliferative disease", Int. J. Hematol., 78, 24 — 31.
- Kawa, K., Okamura, T., Yasui, M., Sato, E. and Inoue, M.. (2002) "Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease", Crit. Rev. Oncol. Hernatol., 44, 251–257.
- Okamura, T., Hatsukawa, Y., Arai, H., Inoue, M. and Kawa, K. (2000) "Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation", Lancet, 356, 223–224.
- Micallef, Mi., Tanimoto, T., Torigoe, K., Nishida, Y., Kohgo, K., Ikegami, H., et al. (1999) "Simultaneous exposure to interleukin-18 and interleukin-10 in vitro synergistically augments murine spleen natural killer cell activity", Cancer Immunology Imunotherapy, 48, 109–117.
- Ratcliffe, M.A., Roditi, G. and Adamson, D.J.A. (1992) "Inter-leukin-2 and splenic enlargement", Journal of the National Cancer Institute, 84, 810–811.
- Janka, G.E. (1983) "Familial hemophagocytic lymphohistiocyto-sis", European Journal of Pediatrics, 140, 221— 230.
- Esumi, N., Ikushima, S., Hibi, S., Todo, S. and Imashuku, S. (1988) "High serum ferritin level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome", Cancer, 61, 2071 —2076.
- Ohshima, K., Shimazaki, K. and Sugihara, M. (1999) "Clinico-pathological findings of virus-associated hemophagocytic syndrome in bone marrow: Association with Epstein-Barr virus and apopto-sis", Pathology International, 49, 533 — 540.